MENU
+Compare
ARGX
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$623.74
Change
-$2.29 (-0.37%)
Capitalization
37.64B

ARGX argenx SE Forecast, Technical & Fundamental Analysis

a manufacturer of antibody-based medicines

Industry Biotechnology
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ARGX with price predictions
Dec 20, 2024

Momentum Indicator for ARGX turns positive, indicating new upward trend

ARGX saw its Momentum Indicator move above the 0 level on December 20, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where ARGX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARGX advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 260 cases where ARGX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ARGX turned negative on December 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARGX broke above its upper Bollinger Band on December 16, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.749) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). ARGX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (21.231) is also within normal values, averaging (256.215).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ARGX is expected to report earnings to fall 10.07% to $1.25 per share on February 27

argenx SE ARGX Stock Earnings Reports
Q4'24
Est.
$1.25
Q3'24
Beat
by $1.24
Q2'24
Beat
by $1.35
Q1'24
Missed
by $0.29
Q4'23
Missed
by $0.36
The last earnings report on October 31 showed earnings per share of $1.39, beating the estimate of 15 cents. With 313.19K shares outstanding, the current market capitalization sits at 37.64B.
A.I. Advisor
published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INFU8.310.35
+4.40%
InfuSystem Holdings
GDDY205.412.47
+1.22%
GoDaddy
REZI24.510.12
+0.49%
Resideo Technologies
NBR53.77-1.02
-1.86%
Nabors Industries Ltd
SSKN2.89-0.16
-5.25%
Strata Skin Sciences

ARGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ARGNF. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ARGNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
-0.35%
ARGNF - ARGX
55%
Loosely correlated
N/A
ROIV - ARGX
47%
Loosely correlated
+0.61%
BBIO - ARGX
46%
Loosely correlated
+1.07%
IMVT - ARGX
44%
Loosely correlated
+0.78%
MDGL - ARGX
43%
Loosely correlated
+5.12%
More